![Julian Gordon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Julian Gordon is the founder of Inspirotec, Inc. and currently holds the title of Chief Scientific Officer.
Postes actifs de Julian Gordon
Sociétés | Poste | Début |
---|---|---|
Inspirotec, Inc.
![]() Inspirotec, Inc. Medical SpecialtiesHealth Technology Inspirotec, Inc. is a company based in North Chicago, IL that provides airborne biological matter detection through indoor air quality companies and experts. The company's highly sensitive patented technology collects and measures biological agents in the air, including viruses such as SARS-CoV-2, allergens, molds, and bacteria down to 0.1 microns. The company's mission is to deliver customized prevention and management solutions to improve health and peace of mind by transforming indoor environments everywhere. The technology has been developed in collaboration with institutions including Johns Hopkins University, the University of Chicago, Harvard University, and Argonne National Laboratory, and has been validated with an extensive portfolio of patents and publications in peer-reviewed literature. The company was founded in 2011 by Julian Gordon, and the CEO is James J. Koziarz. | Fondateur | 01/06/2011 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Inspirotec, Inc.
![]() Inspirotec, Inc. Medical SpecialtiesHealth Technology Inspirotec, Inc. is a company based in North Chicago, IL that provides airborne biological matter detection through indoor air quality companies and experts. The company's highly sensitive patented technology collects and measures biological agents in the air, including viruses such as SARS-CoV-2, allergens, molds, and bacteria down to 0.1 microns. The company's mission is to deliver customized prevention and management solutions to improve health and peace of mind by transforming indoor environments everywhere. The technology has been developed in collaboration with institutions including Johns Hopkins University, the University of Chicago, Harvard University, and Argonne National Laboratory, and has been validated with an extensive portfolio of patents and publications in peer-reviewed literature. The company was founded in 2011 by Julian Gordon, and the CEO is James J. Koziarz. | Health Technology |